Skip to main content
Premium Trial:

Request an Annual Quote

Third Wave Secures $25M Line of Credit

NEW YORK (GenomeWeb News) - Third Wave Technologies said today that it has secured a five-year, $25 million line of credit with healthcare investment company Deerfield Management.
 
Third Wave said it may use the extra capital to market its human papillomavirus tests.
 
The company said any funds it borrows under the facility will have a 7.75 percent interest rate, and an annual two percent non-usage fee will be assessed on the amount the company does not draw.
 
Third Wave also said it has issued a five-year warrant to Deerfield to buy 1.815 million of its shares for $8.36 a share. 

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.